Stock Market US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths By ReutersOctober 11, 20240 (Reuters) – The U.S. Food and Drug Administration has issued a clinical hold on Kezar Life Sciences (NASDAQ:)’ trial of…
Stock Market Cellectar Biosciences reports strong trial results for iopofosineAugust 25, 20240 Cellectar Biosciences (NASDAQ:) shared positive updates during its recent earnings call, highlighting the successful trial results of its lead drug…
